Behavioural Determinants of COVID-19-Vaccine Acceptance in Rural Areas of Six Lower- and Middle-Income CountriesArticle Published on 2022-01-292022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] acceptance acceptor activity Analysis approach Area association Behaviour behavioural conducted Consequences country COVID-19 COVID-19 vaccine COVID-19 vaccines Critical Delayed determinant determinants Efficacy expected global public health Health Hesitancy highest identify identifying include India information Intervention Kenya Local Lower Perceived risk positive provided recommendation refusal risk Self-efficacy severity significantly statistically significant Taking the vaccine vaccination Vaccine was performed [DOI] 10.3390/vaccines10020214 PMC 바로가기 [Article Type] Article
The Influenza Vaccine May Protect Pregnant and Postpartum Women against Severe COVID-19Article Published on 2022-01-282022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] 95% confidence interval Admission antenatal care conducted COVID-19 COVID-19 infection COVID-19 symptoms COVID-19 vaccine database death evaluated Infection Influenza influenza vaccine influenza vaccines intensive care intubation intubation rate Maternal mortality Mortality mortality rate mortality risk National numbers of patient Obstetric Patient Postpartum Pregnancy pregnant pregnant women raised reduce respiratory diseases retrospective cohort study SARS-CoV-2 pandemic Severe COVID-19 Infection severity of COVID-19 significantly higher subject the vaccine vaccination while women [DOI] 10.3390/vaccines10020206 PMC 바로가기 [Article Type] Article
Seroprevalence of SARS-CoV-2 antibodies and knowledge, attitude and practice toward COVID-19 in the Republic of Srpska-Bosnia & Herzegovina: A population-based studySARS-CoV-2 항체의 Seroprevalence 및 Srpska-Bosnia & Herzegovina 공화국의 COVID-19에 대한 지식, 태도 및 관행: 인구 기반 연구Research Article Published on 2022-01-282022-09-12 Journal: PLoS ONE [Category] 진단, [키워드] anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody asked Attitude blood sample Blood samples collected conducted consent form COVID-19 COVID-19 symptom COVID-19 symptoms develop effort ELISA assay hands hands with soap Health Health Education IMPROVE individual individuals Infection Infection transmission knowledge maintain Mask Masks middle opinion physical distance Prevent preventive measure preventive measures questionnaire Randomly required SARS-CoV-2 SARS-CoV-2 antibody selected seronegative seropositive seropositive individual seropositive individuals Seropositivity Seroprevalence serum soap specimen the vaccine Total vaccination [DOI] 10.1371/journal.pone.0262738 PMC 바로가기 [Article Type] Research Article
Cardio-Oncology in the COVID Era (Co & Co): The Never Ending StoryCardiovascular Medicine Published on 2022-01-282022-10-31 Journal: Frontiers in Cardiovascular Medicine [Category] COVID-19, [키워드] abnormal immune response Abnormalities active cancer Affect attack byproduct Cancer cancer patient Cardiotoxicity cardiovascular disease Care Coagulation COVID COVID-19 COVID-19 pandemic COVID-19 vaccines CVD Cytokines damaged described diabetes Efficacy ending Endothelial dysfunction endothelial function Endothelium feature hypertension include Infection Inflammation Intensive likelihood mechanism myocarditis Non-communicable disease outcome pandemic pandemic era Pathogenesis pathophysiologic pathophysiology Patient persistence pharmacological phenotype platform problem rapid expansion recommendation reduced SARS-CoV-2 SARS-CoV-2 infections Side-effect Survivors Symptoms syndemic telehealth the vaccine Toxicity Trigger vaccination variant vascular beds vascular disease venous ventricular ventricular dysfunction [DOI] 10.3389/fcvm.2022.821193 PMC 바로가기 [Article Type] Cardiovascular Medicine
To what extent AstraZeneca ChAdOx1 nCoV-19 vaccine is safe and effective? Rapid systematic reviewReviews Published on 2022-01-282022-10-31 Journal: The Egyptian Journal of Bronchology [Category] COVID-19, [키워드] adverse effect Adverse reaction analyzed article articles AstraZeneca ChAdOx1 nCoV-19 ChAdOx1 nCoV-19 vaccine clinical conducted confirmed case COVID-19 COVID-19 infection Critical database deaths determine Effectiveness Efficacy English language Google Scholar initiated Moderna paper Pfizer–BioNTech Rapid reported retrieved Safe SARS-CoV-2 vaccine selected Seven supplementary material systematic review the vaccine thrombosis thrombotic Trial vaccination Vaccine was performed was recorded [DOI] 10.1186/s43168-021-00109-3 PMC 바로가기 [Article Type] Reviews
Efficacy and safety profile of COVID-19 vaccine in cancer patients: a prospective, multicenter cohort study암 환자에 대한 COVID-19 백신의 효능 및 안전성 프로파일: 전향적, 다기관 코호트 연구Multicenter Study Published on 2022-01-272022-09-12 Journal: Future Oncology [Category] MERS, SARS, 진단, [키워드] affecting antibody Blood blood sample Cancer cancer patient Cancer patients cancer treatment Chemotherapy Control control group CoronaVac COVID-19 COVID-19 vaccine COVID-19 vaccines defined disease disrupting dose effective Efficacy and safety evaluate evaluated Factor high risk highlight IgG IgG antibody immune response Immunotherapy inactivated Inactivated vaccine inactive infection with SARS-CoV-2 levels of antibodies malignancy marker multicenter cohort study Older Patient PROTECT receiving safety profile SARS-CoV-2 SARS-CoV-2 vaccination seropositive significantly lower spike the patient the vaccine vaccination Vaccine virus volunteers were measured [DOI] 10.2217/fon-2021-1248 PMC 바로가기 [Article Type] Multicenter Study
Acceptability of COVID-19 Vaccine Among Hospital Employees in the Department of Paediatrics, Gynaecology and Obstetrics in the University Hospitals of Geneva, SwitzerlandPublic Health Published on 2022-01-272022-10-31 Journal: Frontiers in Public Health [Category] COVID-19, MERS, SARS, [키워드] acceptability chronic disease conducted Contact COVID-19 COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines Critical Department determinant doctor dose employee explained General population gynaecology HCW HCWs health care workers healthcare worker hospital indicate Investment mandatory Nurses obstetrics paediatrics participant participated question Result risk Scientific community severe COVID-19 Side effect Spread Switzerland the disease the vaccine university vaccination Vaccine [DOI] 10.3389/fpubh.2021.781562 PMC 바로가기 [Article Type] Public Health
Atypical Sites of Lymphadenopathy after Anti-COVID-19 Vaccine: Ultrasound FeaturesArticle Published on 2022-01-272022-10-30 Journal: Medicina [Category] COVID-19, SARS, [키워드] anatomical anti-COVID-19 vaccine antigenic Atypical atypical sites complicate cortical COVID-19 demonstrated diagnostic evaluated Evidence feature immune response incidence injection investigated ipsilateral knowledge Lymph node Lymphadenopathy material median age median size mRNA-1273 objective Pathologies pathway Patient patients post-COVID-19 vaccination Prevalence reactive reported Result Retrospective study selected Side effect Site the vaccine tissue Two patient Ultrasound Vaccine vaccine administration vaccine injection Vascular was performed were assessed [DOI] 10.3390/medicina58020197 PMC 바로가기 [Article Type] Article
Duration of Protection against Mild and Severe Disease by Covid-19 VaccinesCovid-19 백신에 의한 경증 및 중증 질병에 대한 보호 기간Article Published on 2022-01-272022-09-11 Journal: The New England Journal of Medicine [Category] 변종, [키워드] 95% CI 95% confidence interval acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Adults age Alpha B.1.1.7 B.1.617.2 BNT162b2 BNT162b2 vaccine BNT162b2 vaccines Case-control cause ChAdOx1 ChAdOx1 nCoV-19 ChAdOx1-S clinical risk clinically condition coronavirus coronavirus disease Coronavirus disease 2019 death delta variant dose Duration effective Effectiveness England greater healthy Hospitalization less medical condition Older peaked protection real-world data receipt SARS-CoV-2 second dose severe acute respiratory syndrome Coronavirus severe disease shown status symptomatic COVID-19 the vaccine United Kingdom vaccination Vaccine vaccine dose variant variants virus [DOI] 10.1056/NEJMoa2115481 PMC 바로가기 [Article Type] Article
Assessing Inequities in COVID-19 Vaccine Roll-Out Strategy Programs: A Cross-Country Study Using a Machine Learning ApproachArticle Published on 2022-01-262022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] a metric adopted Algorithm anticipated approved Assessing association Community condition conditions conducted Containment measure contributed country COVID-19 COVID-19 pandemic COVID-19 vaccine cross-country analysis distribution doses equity Factor Factors forest global public health Haiti Health hospital identify impacted income individual limit lockdown Logistic machine learning mechanism media Mongolia National pandemic Pandemics promote Psychological Random forest reported restrict social distancing Spread Standard deviation Strategy Structure the mean the median the vaccine Transmission vaccination Vaccine Vaccine hesitancy vaccine roll-out virus [DOI] 10.3390/vaccines10020194 PMC 바로가기 [Article Type] Article